New research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning ...

The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients ...

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...

The new year is a time to renew your health goals, and one of the most important ones to add to your list is scheduling ...

Precision medicine is an innovative approach that tailors treatment to the unique genetic and molecular characteristics of a ...